Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9FZD

Structure of OmpA-long in complex with nanobody Nb39

Summary for 9FZD
Entry DOI10.2210/pdb9fzd/pdb
DescriptorOuter membrane protein A, Nanobody 39 (3 entities in total)
Functional Keywordsporin, nanobody, complex, membrane protein
Biological sourceEscherichia coli
More
Total number of polymer chains2
Total formula weight32474.16
Authors
Ackle, F.,Sorgenfrei, M.,Seeger, M.A. (deposition date: 2024-07-05, release date: 2024-07-17, Last modification date: 2025-07-23)
Primary citationSorgenfrei, M.,Hurlimann, L.M.,Printz, A.,Wegner, F.,Morger, D.,Ackle, F.,Remy, M.M.,Montowski, G.,Keserue, H.A.,Cuenod, A.,Imkamp, F.,Egli, A.,Keller, P.M.,Seeger, M.A.
Rapid detection and capture of clinical Escherichia coli strains mediated by OmpA-targeting nanobodies.
Commun Biol, 8:1047-1047, 2025
Cited by
PubMed Abstract: Escherichia coli is a major cause of blood stream and urinary tract infections. Owing to the spread of antimicrobial resistance, it is often treated with an inadequate antibiotic. With the aim to accelerate the diagnostics of this key pathogen, we used the flycode technology to generate nanobodies against the conserved and highly abundant outer membrane protein OmpA. Two nanobodies each recognizing a different isoform of OmpA were shown by flow cytometry to recognize > 91% of 85,680 E. coli OmpA sequences deposited in a large bacterial genome database. Crystal structures of these nanobodies in complex with the respective OmpA isoform revealed interactions with all four surface accessible loops of OmpA. Steric hindrance caused by dense O-antigen layers initially impeded reliable capture of clinical E. coli strains. By generating nanobody constructs with long linkers and by thinning the O-antigen layer through alterations to growth medium and buffers, we achieved to capture < 50 CFU/mL. Our work provides a framework to generate nanobodies for the specific and sensitive detection and capture of clinically relevant pathogenic bacteria.
PubMed: 40659774
DOI: 10.1038/s42003-025-08345-9
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon